OPKO Health, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-10.00
-184.00
-391.00
-14.00
48.00
-304.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
32.00
21.00
42.00
-20.00
-97.00
-68.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-183.00
-28.00
-95.00
38.00
39.00
-172.00
Cash Flow from Investing Activities
352.00
-18.00
91.00
35.00
-18.00
-13.00
Cash Flow from Financing Activities
184.00
-11.00
22.00
-10.00
-35.00
175.00
Net Cash Inflow / Outflow
349.00
-57.00
18.00
62.00
-13.00
-11.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-3.00
0.00
0.00
-1.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of OPKO Health, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-10.362
-157.863
147.00
93.44%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
32.175
-21.601
53.00
248.95%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-183.489
-157.778
-26.00
-16.30%
Cash Flow from Investing Activities
352.214
-290.129
642.00
221.40%
Cash Flow from Financing Activities
184.166
441.449
-257.00
-58.28%
Net Cash Inflow / Outflow
349.734
-6.458
355.00
5515.52%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-3.157
0
-3.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -550.74% vs 70.38% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-183.49
-28.20
-550.74%






